Holen Sie sich die Stockscreener-App
68.81
0.22%
-0.15
Handel nachbörslich:
68.81
Schlusskurs vom Vortag:
$68.96
Offen:
$68.72
24-Stunden-Volumen:
524.00K
Relative Volume:
0.79
Marktkapitalisierung:
$2.90B
Einnahmen:
$17.39M
Nettoeinkommen (Verlust:
$-135.89M
KGV:
-14.83
EPS:
-4.64
Netto-Cashflow:
$-123.00M
1W Leistung:
+4.16%
1M Leistung:
+15.78%
6M Leistung:
+32.56%
1J Leistung:
+54.66%
1-Tages-Spanne:
$68.69
$70.84
1-Wochen-Bereich:
$65.99
$70.84
52-Wochen-Spanne:
$38.51
$76.81
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
Firmenname
Tarsus Pharmaceuticals Inc
Sektor
Branche
Telefon
(949) 409-9820
Adresse
15440 LAGUNA CANYON ROAD, IRVINE
Vergleichen Sie TARS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
68.81 | 2.91B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-20 | Eingeleitet | Goldman | Neutral |
| 2023-07-18 | Eingeleitet | William Blair | Outperform |
| 2023-05-18 | Eingeleitet | Guggenheim | Buy |
| 2022-08-01 | Eingeleitet | Barclays | Overweight |
| 2021-12-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-11-23 | Eingeleitet | Oppenheimer | Outperform |
| 2020-11-10 | Eingeleitet | BofA Securities | Buy |
| 2020-11-10 | Eingeleitet | Jefferies | Buy |
| 2020-11-10 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2020-11-10 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Tarsus Pharmaceuticals Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Tarsus Pharmaceuticals (TARS) to Release Earnings on Tuesday - MarketBeat
What to expect from Tarsus Pharmaceuticals Inc. in the next 30 days2025 Top Gainers & Step-by-Step Trade Execution Guides - newser.com
How analysts rate Tarsus Pharmaceuticals Inc. stock todayTrade Signal Summary & Low Risk Entry Point Guides - newser.com
What’s the recovery path for long term holders of Tarsus Pharmaceuticals Inc.2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com
Can Tarsus Pharmaceuticals Inc. recover in the next quarterPortfolio Profit Report & Safe Capital Growth Tips - newser.com
Top chart patterns to watch in Tarsus Pharmaceuticals Inc.CEO Change & Low Risk High Win Rate Stock Picks - newser.com
Jennison Associates LLC Trims Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Applying sector rotation models to Tarsus Pharmaceuticals Inc.2025 EndofYear Setup & Expert Verified Movement Alerts - newser.com
Will Tarsus Pharmaceuticals Inc. stock deliver shareholder value2025 Market Overview & Weekly High Return Opportunities - newser.com
Is Tarsus Pharmaceuticals Inc. stock poised for growth2025 Market Outlook & Daily Stock Trend Watchlist - newser.com
Forecasting Tarsus Pharmaceuticals Inc. price range with options dataIndex Update & Weekly High Momentum Picks - newser.com
Tarsus Pharmaceuticals Inc. stock trend outlook and recovery pathGold Moves & Risk Controlled Stock Alerts - newser.com
Is Tarsus Pharmaceuticals Inc. stock a safe investment in uncertain marketsTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com
Is Tarsus Pharmaceuticals Inc. stock cheap at current valuation2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Is Tarsus Pharmaceuticals Inc. showing signs of accumulation2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
Full technical analysis of Tarsus Pharmaceuticals Inc. stockWeekly Investment Report & Verified Momentum Watchlists - newser.com
Allianz Asset Management GmbH Purchases New Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Pharmaceuticals, Inc. to Host Live Webcast for Q3 2025 Financial Results and Corporate Update - Quiver Quantitative
Tarsus (NASDAQ: TARS) sets Nov. 4 webcast to share third‑quarter results at 1:30 p.m. PT - Stock Titan
Can Tarsus Pharmaceuticals Inc. stock sustain market leadershipPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Is Tarsus Pharmaceuticals Inc. stock attractive for long term wealth building2025 Dividend Review & Technical Entry and Exit Tips - Fundação Cultural do Pará
How Tarsus Pharmaceuticals Inc. stock performs in weak economy2025 Performance Recap & Daily Entry Point Trade Alerts - Fundação Cultural do Pará
Does Tarsus Pharmaceuticals Inc. qualify in momentum factor screening2025 Technical Patterns & Safe Capital Preservation Plans - newser.com
Will Tarsus Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Volume & Low Risk Entry Point Tips - Fundação Cultural do Pará
Can Tarsus Pharmaceuticals Inc. stock resist market sell offsSell Signal & Smart Allocation Stock Tips - newser.com
Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase - The Motley Fool
Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):